#Paris #France #Smartee #orthodontics #Disneyland

A Landmark Event in Pediatric Orthodontics

On December 18, 2025, the enchanting Disneyland Paris became the backdrop for a remarkable gathering in the field of dental care, as Smartee Denti-Technology successfully hosted the European Children's Orthodontic Summit. This significant event attracted 52 orthodontic professionals from a range of countries including France, Switzerland, Belgium, the Netherlands, Spain, Algeria, Tunisia, and Syria. The central theme of the summit, "Achieving Success with Children through Aligners," focused on enhancing early orthodontic treatments by providing both theoretical insights and practical guidelines on integrating transparent aligners into pediatric care.

The summit was not just another conference; it was an arena where innovation met education. Smartee emphasized its unique approach to pediatric orthodontics, which is characterized by a staged treatment philosophy that grows with the child. This integrated model effectively employs transparent aligners, myofunctional trainers, and functional appliances to create a unified system aimed at young patients. Engagement and compliance from patients remain crucial, particularly within pediatric practices, and Smartee aims to foster a supportive environment to achieve this.

A Touch of Disney Magic

Since the launch of their first early orthodontic product featuring officially licensed Disney character packaging in February 2022 in China, Smartee has strategically expanded its reach to over 63 countries and regions around the globe as of 2024. Notable Disney characters such as Elsa, Spider-Man, Iron Man, and Stitch have been cleverly incorporated into their pediatric orthodontic solutions. This collaboration, highlighted during the European Children’s Orthodontic Summit, is designed to make orthodontic treatment more engaging for young patients while keeping clinical rigor intact. The inclusion of beloved characters not only enhances the patient experience but also encourages long-term adherence to treatment plans, helping children feel more comfortable throughout their orthodontic journey.

A Shift Towards Guidance

The event brought together prominent orthodontists, including Pascal Baron, Dimitri Pascual, Paulo Retto, Constance Laloze, Capucine Batut, and Anne-Claire Loiseau. They shared clinical knowledge and expertise on early orthodontic intervention. Professor Pascal Baron emphasized the importance of shifting from a traditional treatment-centric approach to a growth-oriented perspective. He asserted that early orthodontics is not merely about repositioning teeth but rather creating a balanced environment that supports the child’s dynamic growth—aligning teeth, jaw, and facial structure harmoniously.

Dr. Adrien Bizet reiterated this sentiment, pointing out that early intervention plays a pivotal role in managing jaw and dental development. He commended Smartee for their integrated mandibular advancement systems, which transform aligners into a clinically relevant solution for early management of jaw retrognathism.

Driving Clinical Collaboration Across Europe

This summit served as more than just an academic exchange; it created a vital platform for promoting collaboration within pediatric orthodontics across Europe. Smartee reaffirmed its commitment to evidence-based education and advancing transparent aligner solutions for children and adolescents. The company continues to collaborate with clinical professionals, educators, and researchers to support the evolution of early orthodontic care, ensuring that children across Europe receive the best possible treatment.

Conclusion

The successful hosting of the European Children's Orthodontic Summit at Disneyland Paris by Smartee marks a significant milestone in the field of pediatric orthodontics. By blending clinical innovation with engaging treatment experiences, Smartee is not only revolutionizing how orthodontics is delivered to young patients but also reinforcing its commitment to making pediatric care more accessible and effective without compromising treatment integrity.